0
Heron Therapeutics Inc Banner Image

Heron Therapeutics Inc

  • Ticker HRTX
    Exchange NASDAQ More
  • Industry Drug Manufacturers - Other More
  • Sector Healthcare More
Heron Therapeutics Inc Logo Image
  • 51-200 Employees
  • Based in San Diego, California
Heron Therapeutics, Inc. is a biotechnology company. The Company uses its technology to develop products to address unmet medical needs. Its Biochronomer polymer-based drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals. The Company's product candidate, SUSTOL (granisetron injection, extended release), is being developed for the preventionMore of both acute- and delayed-onset chemotherapy-induced nausea and vomiting (CINV). Sustol is in Phase III Clinical trials. The Company's product development program also focuses on identifying new delivery methods and formulations utilizing known compounds that may expand or extend the therapeutic effort, or eliminate the drawbacks of current therapies. The Company's other product candidates include HTX-019 for CINV, which is in Preclinical state; HTX-011 for Post-operative pain management, which is in Phase I trials, and HTX-003 for chronic pain management, which is in Preclinical state.
Heron Therapeutics Inc

Most Recent Annual Report

Heron Therapeutics Inc MOST RECENT 2020 Annual Report and Form 10K

Report Locked. Heron Therapeutics Inc has reached its limit for free report views.

Older/Archived Annual Reports